Autonomous Allergic Reaction Response System
Legal Citation
Summary of the Inventive Concept
A next-generation, wearable, and autonomous system that detects and responds to allergic reactions, providing personalized emergency response plans and medication administration.
Background and Problem Solved
The original tamper-evident closure container patent addressed the need for proper preparation and access to equipment in emergency situations, but it did not account for the complexities of modern allergic reactions. The new inventive concept solves the problem of delayed or inadequate response to allergic reactions by introducing autonomous detection, personalized response plans, and advanced medication administration.
Detailed Description of the Inventive Concept
The Autonomous Allergic Reaction Response System comprises a wearable, autonomous container that detects allergic reactions and injects medication via a retractable needle. The system is powered by a bio-compatible energy harvesting system and features interchangeable cartridges containing different medications. The system also includes a sensor for detecting expiration dates and medication levels, and a user interface for tracking and managing medication regimens. Furthermore, the system integrates with a network-enabled, AI-powered platform for monitoring and responding to allergic reactions, providing personalized alerts and instructions to users and emergency responders.
Novelty and Inventive Step
The new claims introduce autonomous detection and response capabilities, wearable and implantable devices, and AI-powered platforms, which are not present in the original patent. These features provide a significant inventive step, enabling a more comprehensive and effective response to allergic reactions.
Alternative Embodiments and Variations
Alternative embodiments of the Autonomous Allergic Reaction Response System could include implantable devices with longer lifetimes, or integration with existing wearable devices such as smartwatches. Variations could also include different types of medication administration, such as inhalers or transdermal patches.
Potential Commercial Applications and Market
The Autonomous Allergic Reaction Response System has significant commercial potential in the healthcare and medical device industries, particularly in the areas of emergency response, allergy treatment, and personalized medicine. The system could be marketed to individuals with severe allergies, as well as to healthcare providers and emergency responders.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/002 |
| A | A61 | A61M5/31501 |
| A | A61 | A61M5/31525 |
| A | A61 | A61M5/50 |
| B | B65 | B65D55/06 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical Device Design and Emergency Medical Response Systems, focusing on medication delivery devices, specifically for anaphylaxis treatment and emergency drug administration
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in drug delivery systems, emergency medical technologies, and human-machine interfaces, typically holding a master's or doctoral degree with 3-5 years of industry experience
Obviousness Rationale
A PHOSITA would recognize that the published technical disclosure represents a natural technological progression from the source patent's emergency medication container, extending the core concept of rapid medication delivery through predictable technological advancements in sensing, autonomy, and personalized medical response systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,754 |
|---|---|
| Title | Tamper evident closure container |